Gregory Bailey, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 16,604 shares at $78.98 ($1.3M) on 2020-10-19, disclosed to the SEC on 2020-10-21.
Open-market sale of $1.3M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.88 | 3,748 | $296K | 22.6% |
| 2 | $78.88 | 3,748 | $296K | 22.6% |
| 3 | $78.98 | 4,554 | $360K | 27.4% |
| 4 | $78.98 | 4,554 | $360K | 27.4% |
| Total | $78.93 avg | 16,604 | $1.3M | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |